41
Participants
Start Date
October 29, 2009
Primary Completion Date
February 14, 2013
Study Completion Date
February 14, 2013
Anti-NGF AB
Solution for injection, 10 mg, one injection/8 weeks
Fejer Megyei Szt. Gyorgy Korhaz - Rendelointezet/Aneszteziologiai es Intenziv Betegellato Osztaly, Székesfehérvár
General Hospital Varazdin, Varaždin
WK River Cities Clinical Research Center, Shreveport
Clinic of Oncology, Banja Luka
Huntsman Cancer Institute, Salt Lake City
UCSD Moores Cancer Center, La Jolla
Chhatrapati Shahuji Maharaj Medical University, Lucknow
UCSD Center for Pain Medicine, La Jolla
UCSD Medical Center - Thornton Hospital, La Jolla
UCSD Periman Ambulatory Care Center, La Jolla
Nuhr Zentrum, Senftenberg
Central India Cancer Research Institute Central India Cancer Research Institute, Nagpur
Shatabdi Super Speciality Hospital, Nashik
Latvian Oncology Centre, Riga
Niepubliczny Zaklad Opieki Zdrowotnej, Bydgoszcz
Hospicjum im Ks Eugeniusza Dutkiewicza SAC w Gdansku, Gdansk
**Poradnia Medycyny Paliatywnej, Hospicjum Palium, Poznan
Wielkopolskie Centrum Onkologii im. Marii Sklodowskiej-Curie, Poznan
NZOZ Zespol Opieki Domowej Polskiego Towarzystwa Opieki Paliatywnej, Włocławek
Fakultna Nemocina s Poliklinikou FD Roosevelta Banska Bystrica, Banská Bystrica
Narodny onkologicky ustav, Bratislava
Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu
Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Seoul
Lead Sponsor
Pfizer
INDUSTRY